NDC codes

FDA NDC Directory
Product NDC (as listed)80425-0100Labeler and product segments. Claims need a package NDC.
Product NDC at billing width80425-0100Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
80425-0100-18042501000130 TABLET in 1 BOTTLE (80425-0100-1)Marketed from Jul 11, 2024
80425-0100-28042501000260 TABLET in 1 BOTTLE (80425-0100-2)Marketed from Dec 25, 1995

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Alprazolam
Generic name (nonproprietary)
alprazolam
Active ingredients
Alprazolam — 1 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 074112
Marketing start
Marketing end
DEA schedule
CIV
Other FDA classes
Benzodiazepines (Chemical structure)
Identifiers
Product ID 80425-0100_1cfab3cb-1866-f860-e063-6294a90a464dSPL ID 1cfab3cb-1866-f860-e063-6294a90a464dSPL set ID b39e2bc8-b691-0f4e-e053-2995a90a00fdRxCUI 197321UNII YU55MQ3IZY
Pharmacologic class
Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480425010001 followed by a unit qualifier and the quantity

Package 80425-0100-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

1. Indications and Usage Alprazolam tablets are indicated for the: •acute treatment of generalized anxiety disorder (GAD) in adults. •treatment of panic disorder (PD), with or without agoraphobia in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 074112

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 074112
ProductStrengthForm · routeLabelerProduct NDC
AlprazolamAlprazolam .25 mg/1TabletOralProficient Rx LP63187-916
AlprazolamAlprazolam .5 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC71610-734
AlprazolamAlprazolam 1 mg/1TabletOralA-S Medication Solutions50090-2896
AlprazolamAlprazolam .5 mg/1TabletOralProficient Rx LP63187-225
AlprazolamAlprazolam .25 mg/1TabletOralA-S Medication Solutions50090-1864
AlprazolamAlprazolam .25 mg/1TabletOralSandoz Inc0781-1061
AlprazolamAlprazolam .5 mg/1TabletOralSandoz Inc0781-1077
AlprazolamAlprazolam .5 mg/1TabletOralAdvanced Rx of Tennessee, LLC80425-0284
AlprazolamAlprazolam 1 mg/1TabletOralSandoz Inc0781-1079
AlprazolamAlprazolam 1 mg/1TabletOralProficient Rx LP63187-443
AlprazolamAlprazolam 1 mg/1TabletOralPD-Rx Pharmaceuticals, Inc.43063-609
AlprazolamAlprazolam .25 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC71610-696
AlprazolamAlprazolam 1 mg/1TabletOralREMEDYREPACK INC.70518-4137

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in